$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[해외논문] Cyclic Peptide Mimotopes for the Detection of Serum Anti–ATIC Autoantibody Biomarker in Hepato-Cellular Carcinoma 원문보기

International journal of molecular sciences, v.21 no.24, 2020년, pp.9718 -   

Heo, Chang-Kyu (Rare Disease Research Center, Korea Research Institute of Bioscience and Biotechnology, 125 Gwahak-ro, Yuseong-gu, Daejeon 34141, Korea) ,  Hwang, Hai-Min (ckheo40@kribb.re.kr (C.-K.H.)) ,  Lim, Won-Hee (purity-32@hanmail.net (H.-M.H.)) ,  Lee, Hye-Jung (wonhee@kribb.re.kr (W.-H.L.)) ,  Yoo, Jong-Shin (Rare Disease Research Center, Korea Research Institute of Bioscience and Biotechnology, 125 Gwahak-ro, Yuseong-gu, Daejeon 34141, Korea) ,  Lim, Kook-Jin (ckheo40@kribb.re.kr (C.-K.H.)) ,  Cho, Eun-Wie (purity-32@hanmail.net (H.-M.H.))

Abstract AI-Helper 아이콘AI-Helper

Tumor-associated (TA) autoantibodies have been identified at the early tumor stage before developing clinical symptoms, which holds hope for early cancer diagnosis. We identified a TA autoantibody from HBx-transgenic (HBx-tg) hepatocellular carcinoma (HCC) model mouse, characterized its target antig...

Keyword

참고문헌 (40)

  1. 1. Bray F. Ferlay J. Soerjomataram I. Siegel R.L. Torre L.A. Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J. Clin. 2018 68 394 424 10.3322/caac.21492 30207593 

  2. 2. United Nations Development Programme Human Development Report 2016: Human Development for Everyone United Nations Development Programme New York, NY, USA 2016 

  3. 3. Zaenker P. Gray E.S. Ziman M.R. Autoantibody Production in Cancer―The Humoral Immune Response toward Autologous Antigens in Cancer Patients Autoimmun. Rev. 2016 15 477 483 10.1016/j.autrev.2016.01.017 26827909 

  4. 4. Rauf F. Anderson K.S. LaBaer J. Autoantibodies in early detection of breast cancer Cancer Epidemiol. Biom. Prev. 2020 29 2475 2485 10.1158/1055-9965.EPI-20-0331 32994341 

  5. 5. Xu L. Lee J.R. Hao S. Ling X.B. Brooks J.D. Wang S.X. Gambhir S.S. Improved detection of prostate cancer using a magneto-nanosensor assay for serum circulating autoantibodies PLoS ONE 2019 14 e0221051 31404106 

  6. 6. Wang X. Yu J. Sreekumar A. Varambally S. Shen R. Giacherio D. Mehra R. Montie J.E. Pienta K.J. Sanda M.G. Autoantibody signatures in prostate cancer N. Engl. J. Med. 2005 353 1224 1235 10.1056/NEJMoa051931 16177248 

  7. 7. Qin J. Zeng N. Yang T. Wan C. Chen L. Shen Y. Wen F. Diagnostic Value of Autoantibodies in Lung Cancer: A Systematic Review and Meta-Analysis Cell Physiol. Biochem. 2018 51 2631 2646 10.1159/000495935 30562746 

  8. 8. Wang H. Li X. Zhou D. Huang J. Autoantibodies as biomarkers for colorectal cancer: A systematic review, meta-analysis, and bioinformatics analysis Int. J. Biol. Markers 2019 34 334 347 10.1177/1724600819880906 31588830 

  9. 9. Elias K.M. Guo J. Bast R.C. Jr. Early Detection of Ovarian Cancer Hematol. Oncol. Clin. N. Am. 2018 32 903 914 10.1016/j.hoc.2018.07.003 

  10. 10. Fortner R.T. Damms-Machado A. Kaaks R. Systematic review: Tumor-associated antigen autoantibodies and ovarian cancer early detection Gynecol. Oncol. 2017 147 465 480 10.1016/j.ygyno.2017.07.138 28800944 

  11. 11. Koziol J.A. Imai H. Dai L. Zhang J. Tan E.M. Early detection of hepatocellular carcinoma using autoantibody profiles from a panel of tumor-associated antigens Cancer Immunol. Immunother. 2018 67 835 841 10.1007/s00262-018-2135-y 29497780 

  12. 12. Nunez C. Blood-based protein biomarkers in breast cancer Clin. Chim. Acta 2019 490 113 127 10.1016/j.cca.2018.12.028 30597138 

  13. 13. Hanash S.M. Ostrin E.J. Fahrmann J.F. Blood based biomarkers beyond genomics for lung cancer screening Transl. Lung Cancer Res. 2018 7 327 335 10.21037/tlcr.2018.05.13 30050770 

  14. 14. Kalnia Z. Meistere I. Kikuste I. Tolmanis I. Zayakin P. Lin A. Emerging blood-based biomarkers for detection of gastric cancer World J. Gastroenterol. 2015 21 11636 11653 26556992 

  15. 15. Ludwig N. Whiteside T.L. Reichert T.E. Challenges in Exosome Isolation and Analysis in Health and Disease Int. J. Mol. Sci. 2019 20 4684 10.3390/ijms20194684 31546622 

  16. 16. Macdonald I.K. Parsy-Kowalska C.B. Chapman C.J. Autoantibodies: Opportunities for Early Cancer Detection Trends Cancer 2017 3 198 213 28718432 

  17. 17. Royahem J. Conrad K. Frey M. Melhom J. Frank K.H. Autoantibodies Predictive Parameters of Tumor Development Pathogenic and Diagnostic Relevance of Autoantibodies Konrad K. Humboldt R.L. Meurer M. Shoenfeld Y. Tan E.M. Pabst Berlin, Germany 1988 412 414 

  18. 18. Kobayashi M. Katayama H. Fahrmann J.F. Hanash S.M. Development of autoantibody signatures for common cancers Semin Immunol. 2020 47 101388 10.1016/j.smim.2020.101388 31924500 

  19. 19. Heo C.K. Hwang H.M. Lee H.J. Kwak S.S. Yoo J.S. Yu D.Y. Lim K.J. Lee S. Cho E.W. Serum anti-EIF3A autoantibody as a potential diagnostic marker for hepatocellular carcinoma Sci. Rep. 2019 9 11059 10.1038/s41598-019-47365-4 31363116 

  20. 20. Yu D.Y. Moon H.B. Son J.K. Jeong S. Yu S.L. Yoon H. Han Y.M. Lee C.S. Park J.S. Lee C.H. Incidence of hepatocellular carcinoma in transgenic mice expressing the hepatitis B virus X-protein J. Hepatol. 1999 31 123 132 10.1016/S0168-8278(99)80172-X 10424292 

  21. 21. Wang A.G. Moon H.B. Lee M.R. Hwang C.Y. Kwon K.S. Yu S.L. Kim Y.S. Kim M. Kim J.M. Kim S.K. Gender-dependent hepatic alterations in H-ras12V transgenic mice J. Hepatol. 2005 43 836 844 10.1016/j.jhep.2005.04.012 16087271 

  22. 22. Hwang H.M. Heo C.K. Lee H.J. Kwak S.S. Lim W.H. Yoo J.S. Yu D.Y. Lim K.J. Kim J.Y. Cho E.W. Identification of anti-SF3B1 autoantibody as a diagnostic marker in patients with hepatocellular carcinoma J. Transl. Med. 2018 16 177 29954402 

  23. 23. Heo C.K. Hwang H.M. Ruem A. Yu D.Y. Lee J.Y. Yoo J.S. Kim I.G. Yoo H.S. Oh S. Ko J.H. Identification of a mimotope for circulating anti-cytokeratin 8/18 antibody and its usage for the diagnosis of breast cancer Int. J. Oncol. 2013 42 65 74 10.3892/ijo.2012.1679 23128437 

  24. 24. Heo C.K. Woo M.K. Yu D.Y. Lee J.Y. Yoo J.S. Yoo H.S. Ko J.H. Kim J.M. Choi J.Y. Kim I.G. Identification of autoantibody against fatty acid synthase in hepatocellular carcinoma mouse model and its application to diagnosis of HCC Int. J. Oncol. 2010 36 1453 1459 20428769 

  25. 25. Capello M. Vykoukal J.V. Katayama H. Bantis L.E. Wang H. Kundnani D.L. Aguilar-Bonavides C. Aguilar M. Tripathi S.C. Dhillon D.S. Exosomes harbor B cell targets in pancreatic adenocarcinoma and exert decoy function against complement-mediated cytotoxicity Nat. Commun. 2019 10 254 10.1038/s41467-018-08109-6 30651550 

  26. 26. Ghosh D. Lippert D. Krokhin O. Cortens J.P. Wilkins J.A. Defining the membrane proteome of NK cells J. Mass Spectrom. 2010 45 1 25 10.1002/jms.1696 19946888 

  27. 27. Welton J.L. Khanna S. Giles P.J. Brennan P. Brewis I.A. Staffurth J. Mason M.D. Clayton A. Proteomics analysis of bladder cancer exosomes Mol. Cell Proteom. 2010 9 1324 1338 10.1074/mcp.M000063-MCP201 

  28. 28. Liang B. Peng P. Chen S. Li L. Zhang M. Cao D. Yang J. Li H. Gui T. Li X. Characterization and proteomic analysis of ovarian cancer-derived exosomes J. Proteom. 2013 80 171 182 10.1016/j.jprot.2012.12.029 

  29. 29. Lazar I. Clement E. Ducoux-Petit M. Denat L. Soldan V. Dauvillier S. Balor S. Burlet-Schiltz O. Larue L. Muller C. Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines Pigm. Cell Melan. Res. 2015 28 464 475 10.1111/pcmr.12380 

  30. 30. Riedinger C. Mendler M. Schlotterer A. Fleming T. Okun J. Hammes H.P. Herzig S. Nawroth P.P. High-glucose toxicity is mediated by AICAR-transformylase/IMP cyclohydrolase and mitigated by AMP-activated protein kinase in Caenorhabditis elegans J. Biol. Chem. 2018 293 4845 4859 10.1074/jbc.M117.805879 29414769 

  31. 31. Torres M.J. Turell L. Botti H. Antmann L. Carballal S. Ferrer-Sueta G. Radi R. Alvarez B. Modulation of the reactivity of the thiol of human serum albumin and its sulfenic derivative by fatty acids Arch. Biochem. Biophys. 2012 521 102 110 10.1016/j.abb.2012.03.011 22450170 

  32. 32. Yin J. Ren W. Huang X. Deng J. Li T. Yin Y. Potential Mechanisms Connecting Purine Metabolism and Cancer Therapy Front. Immunol. 2018 9 1697 10.3389/fimmu.2018.01697 30105018 

  33. 33. Vergis J.M. Beardsley G.P. Catalytic mechanism of the cyclohydrolase activity of human aminoimidazole carboxamide ribonucleotide formyltransferase/inosine monophosphate cyclohydrolase Biochemistry 2004 43 1184 1192 10.1021/bi035139b 14756554 

  34. 34. Tureci O. Usener D. Schneider S. Sahin U. Identification of tumor-associated autoantigens with SEREX Methods Mol. Med. 2005 109 137 154 15585919 

  35. 35. He Y. Wu Y. Mou Z. Li W. Zou L. Fu T. Zhang A. Xiang D. Xiao H. Wang X. Proteomics-based identification of HSP60 as a tumor-associated antigen in colorectal cancer Proteom. Clin. Appl. 2007 1 336 342 10.1002/prca.200600718 21136683 

  36. 36. Hardouin J. Lasserre J.P. Sylvius L. Joubert-Caron R. Caron M. Cancer immunomics: From serological proteome analysis to multiple affinity protein profiling Ann. N. Y. Acad. Sci. 2007 1107 223 230 10.1196/annals.1381.024 17804550 

  37. 37. Raposo G. Stoorvogel W. Extracellular vesicles: Exosomes, microvesicles, and friends J. Cell Biol. 2013 200 373 383 10.1083/jcb.201211138 23420871 

  38. 38. van Niel G. D’Angelo G. Raposo G. Shedding light on the cell biology of extracellular vesicles Nat. Rev. Mol. Cell Biol. 2018 19 213 228 10.1038/nrm.2017.125 29339798 

  39. 39. Minciacchi V.R. Freeman M.R. Di Vizio D. Extracellular vesicles in cancer: Exosomes, microvesicles and the emerging role of large oncosomes Semin. Cell Dev. Biol. 2015 40 41 51 10.1016/j.semcdb.2015.02.010 25721812 

  40. 40. Livshits M.A. Khomyakova E. Evtushenko E.G. Lazarev V.N. Kulemin N.A. Semina S.E. Generozov E.V. Govorun V.M. Isolation of exosomes by differential centrifugation: Theoretical analysis of a commonly used protocol Sci. Rep. 2015 5 17319 10.1038/srep17319 26616523 

LOADING...

활용도 분석정보

상세보기
다운로드
내보내기

활용도 Top5 논문

해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.

관련 콘텐츠

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

유발과제정보 저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로